Skip to main content

Table 3 Overview of treatment/therapy received

From: Insights from the European Nontuberculous mycobacterial pulmonary disease PAtient Disease Experience (ENPADE) survey– exploring disease burden and impact

Country

Observed by physician without specific treatment/therapy

% (n)

Neither treatment/therapy nor observation

% (n)

Treatment/therapy received

% (n)

Total

% (n)

United Kingdom

21.0% (16)

19.7% (15)

59.2% (45)

100.0% (76)

Germany

15.6% (12)

2.6% (2)

81.8% (63)

100.0% (77)

Italy

4.8% (3)

8.0% (5)

87.1% (54)

100.0% (62)

France

19.0% (8)

0.0% (0)

80.9% (34)

100.0% (42)

Spain

25.0% (5)

5.0% (1)

70.0% (14)

100.0% (20)

Belgium

4.3% (1)

17.4% (4)

78.3% (18)

100.0% (23)

the Netherlands

33.3% (4)

16.7% (2)

50.0% (6)

100.0% (12)

Austria

0.0% (0)

20.0% (1)

80.0% (4)

100.0% (5)

Total

15.4% (49)

9.5% (30)

75.1% (238)

100.0% (317)

  1. Total population = 468 patients; Question did not specify which treatments/therapies are applicable